Obstructive Sleep Apnoea and Adipose Tissue Dysfunction
Launched by ROYAL DEVON AND EXETER NHS FOUNDATION TRUST · Aug 5, 2015
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
Assessment includes a adipose tissue biopsy and measurement of oxygenation and blood flow by a Clarke type electrodes and non-invasive Doppler techniques.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • men with or without obstructive sleep apnoea
- Exclusion Criteria:
- • weight loss interventions
- • steroid use
- • active smoking
About Royal Devon And Exeter Nhs Foundation Trust
The Royal Devon and Exeter NHS Foundation Trust is a leading healthcare organization dedicated to delivering high-quality patient care and advancing medical research. Located in Exeter, the Trust is committed to innovation and excellence in clinical trials, facilitating studies that aim to improve health outcomes and enhance treatment options across various medical disciplines. With a strong emphasis on collaboration, the Trust partners with researchers, healthcare professionals, and patients to foster a research environment that prioritizes safety, ethical standards, and scientific integrity. Through its robust infrastructure and expertise, the Royal Devon and Exeter NHS Foundation Trust plays a vital role in the advancement of evidence-based medicine and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Exeter, , United Kingdom
Exeter, , United Kingdom
Patients applied
Trial Officials
Katarina Kos, FRCP,PhD
Principal Investigator
University of Exeter
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials